Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3674201013 | Cefaclor (as cefaclor monohydrate) 375 mg prolonged-release oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
3674202018 | Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Has manufactured dose form | Prolonged-release oral tablet | false | Inferred relationship | Some | ||
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Has presentation strength numerator value | 375 | false | Inferred relationship | Some | 1 | |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Has unit of presentation | Tablet (unit of presentation) | false | Inferred relationship | Some | ||
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. | Cefaclor (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | This attribute specifies the denominator unit for the presentation strength of a product. | Tablet (unit of presentation) | false | Inferred relationship | Some | 1 | |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Has presentation strength denominator value | un | false | Inferred relationship | Some | 1 | |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | This attribute specifies the numerator unit for the presentation strength of a product. | mg | false | Inferred relationship | Some | 1 | |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). | Cefaclor monohydrate (substance) | false | Inferred relationship | Some | 1 | |
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Is a | Product containing cefaclor in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Count of base of active ingredient | un | false | Inferred relationship | Some | ||
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Is a | Product containing only cefaclor in oral dose form (medicinal product form) | false | Inferred relationship | Some | ||
Product containing precisely cefaclor (as cefaclor monohydrate) 375 milligram/1 each prolonged-release oral tablet | Plays role | Antibacterial therapeutic role (role) | false | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set (foundation metadata concept)